Upgrade to SI Premium - Free Trial

Leerink Swann Downgrades Salix Pharmaceuticals (SLXP) to Market Perform

February 23, 2015 7:21 AM
Leerink Swann downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades

Next Articles